US Patent Litigations are now available. Check here

IP Verse

Egis Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag patent opposition analysis

Latest oppositions filed by Egis Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag

Explore patent oppositions filed by Egis Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jun 26, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3626270	New Use	NOVARTIS	Jul 8, 2024
EP3294283	Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure	NOVARTIS	Oct 9, 2023
EP2959894	S1P Receptor Modulators For Treating Multiple Sclerosis	NOVARTIS	Jul 11, 2023
EP2234617	Dosing Regimen Associated With Long Acting Injectable Paliperidone Esters	JANSSEN PHARMACEUTICA	Dec 31, 2021
EP2981271	Therapeutic Uses Of Empagliflozin	BOEHRINGER INGELHEIM	Aug 12, 2019

Top competitors of Egis Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag

NOVARTIS

JANSSEN PHARMACEUTICA

BOEHRINGER INGELHEIM